Explore our scientific resources

Get our newsletters

Published on the 25 June 2019

ETAP-Cell: a new in vitro pharmacology service for drug research in neurodegenerative diseases – Newsletter #5

The ETAP-Cell project continues to make progress as per the expected timeline. The whole team is delighted to announce that the in vitro laboratory is now fully equipped and already producing its firs…

Technical notes
Published on the 16 May 2019

Strok@lliance – Newsletter #5

Newsletter #5 Topics: I) Strok@lliance’s scientific conference will be held every two years: see you in spring 2020!II) European Stroke Action Plan 2018–2030: What about preclinical science?III…

Technical notes
Published on the 21 March 2019

Publication: “Isoproterenol-induced heart failure in rat heart: evaluation and cardioprotective strategy.”

Research publication titled: "Isoproterenol-induced heart failure in rat heart: evaluation and cardioprotective strategy." G. Bourdier, et al. SYNCROSOME. Presented during Printemps de la Cardiologie …

Publications
Published on the 17 December 2018

ETAP-Lab, 2018 – Newsletter #4

Within the framework of the European project MEDILIGHT, the consortium selected ETAP-Lab to outsource a preclinical study aiming at evaluating the efficacy of a miniaturized smart system built up to i…

Technical notes
Published on the 1 November 2018

Newsletter #3

New ETAP-Lab studies on TEMISIS’ drug candidate TEM1657 for Psoriasis ETAP-Lab performed new studies for the account of TEMISIS on a mouse imiquimod-induced psoriasis model. The output of thes…

Technical notes
Published on the 4 October 2018

Strok@lliance – Newsletter #4

Post-stroke deficits and recovery from bench to patient’s bed This year again, Strok@lliance aimed at bridging the gap between laboratory and clinical practices. The event occured at…

Technical notes
Published on the 1 October 2018

Newsletter #2

ETAP-Lab supports Plant Advanced Technologies in the development of its TEM1657 compound for the treatment of psoriasis TEM1657 is a drug candidate discovered and optimized by Plant Advanced Techno…

Technical notes
Published on the 20 June 2018

Evaluation of the antidepressant- and anxiolytic-like effects of a hydrophilic extract from the green seaweed Ulva sp. in rats

OBJECTIVES: The green seaweed Ulva sp. contains a large amount of ulvans, a family of sulphated polysaccharides. The present study was designed to investigate in rats the antidepressant- and anxiolyti…

Publications